243 related articles for article (PubMed ID: 17974917)
1. FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of Arf.
Bouchard C; Lee S; Paulus-Hock V; Loddenkemper C; Eilers M; Schmitt CA
Genes Dev; 2007 Nov; 21(21):2775-87. PubMed ID: 17974917
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Bertwistle D; Sherr CJ
Blood; 2007 Jan; 109(2):792-4. PubMed ID: 16968893
[TBL] [Abstract][Full Text] [Related]
4. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
5. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF.
Jacobs JJ; Scheijen B; Voncken JW; Kieboom K; Berns A; van Lohuizen M
Genes Dev; 1999 Oct; 13(20):2678-90. PubMed ID: 10541554
[TBL] [Abstract][Full Text] [Related]
6. FoxO3 suppresses Myc-driven lymphomagenesis.
Vandenberg CJ; Motoyama N; Cory S
Cell Death Dis; 2016 Jan; 6(1):e2046. PubMed ID: 26764572
[TBL] [Abstract][Full Text] [Related]
7. Arf tumor suppressor disrupts the oncogenic positive feedback loop including c-Myc and DDX5.
Tago K; Funakoshi-Tago M; Itoh H; Furukawa Y; Kikuchi J; Kato T; Suzuki K; Yanagisawa K
Oncogene; 2015 Jan; 34(3):314-22. PubMed ID: 24469041
[TBL] [Abstract][Full Text] [Related]
8. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis.
Post SM; Quintás-Cardama A; Terzian T; Smith C; Eischen CM; Lozano G
Oncogene; 2010 Mar; 29(9):1260-9. PubMed ID: 19935700
[TBL] [Abstract][Full Text] [Related]
9. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.
Schmitt CA; McCurrach ME; de Stanchina E; Wallace-Brodeur RR; Lowe SW
Genes Dev; 1999 Oct; 13(20):2670-7. PubMed ID: 10541553
[TBL] [Abstract][Full Text] [Related]
10. Oncogenic c-Myc-induced lymphomagenesis is inhibited non-redundantly by the p19Arf-Mdm2-p53 and RP-Mdm2-p53 pathways.
Meng X; Carlson NR; Dong J; Zhang Y
Oncogene; 2015 Nov; 34(46):5709-17. PubMed ID: 25823025
[TBL] [Abstract][Full Text] [Related]
11. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss.
Baudino TA; Maclean KH; Brennan J; Parganas E; Yang C; Aslanian A; Lees JA; Sherr CJ; Roussel MF; Cleveland JL
Mol Cell; 2003 Apr; 11(4):905-14. PubMed ID: 12718877
[TBL] [Abstract][Full Text] [Related]
12. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
Evans-Anderson HJ; Alfieri CM; Yutzey KE
Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
[TBL] [Abstract][Full Text] [Related]
14. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
15. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
16. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N
Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064
[TBL] [Abstract][Full Text] [Related]
17. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase.
Shreeram S; Hee WK; Demidov ON; Kek C; Yamaguchi H; Fornace AJ; Anderson CW; Appella E; Bulavin DV
J Exp Med; 2006 Dec; 203(13):2793-9. PubMed ID: 17158963
[TBL] [Abstract][Full Text] [Related]
18. CDK4 deficiency promotes genomic instability and enhances Myc-driven lymphomagenesis.
Lu Y; Wu Y; Feng X; Shen R; Wang JH; Fallahi M; Li W; Yang C; Hankey W; Zhao W; Ganju RK; Li MO; Cleveland JL; Zou X
J Clin Invest; 2014 Apr; 124(4):1672-84. PubMed ID: 24614102
[TBL] [Abstract][Full Text] [Related]
19. Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
Sugihara E; Shimizu T; Kojima K; Onishi N; Kai K; Ishizawa J; Nagata K; Hashimoto N; Honda H; Kanno M; Miwa M; Okada S; Andreeff M; Saya H
Oncogene; 2012 Jun; 31(23):2849-61. PubMed ID: 21986948
[TBL] [Abstract][Full Text] [Related]
20. FoxO transcription factors 1 regulate mouse preimplantation embryo development.
Kuscu N; Gungor-Ordueri NE; Sozen B; Adiguzel D; Celik-Ozenci C
J Assist Reprod Genet; 2019 Oct; 36(10):2121-2133. PubMed ID: 31396850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]